Details van artikel 541 van 1699 gevonden artikelen
PO-05-115 DETERMINING ELIGIBILITY FOR RIDGETM-1, A PHASE 1B INTERVENTIONAL STUDY TO EVALUATE SAFETY AND EFFICACY OF TN-401 GENE THERAPY IN ADULTS WITH PLAKOPHILIN-2 (PKP2)-ASSOCIATED ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (ARVC): INTERIM RESULTS OF AN OBSERVATIONAL STUDY TO ASSESS SEROPREVALENCE TO ADENO-ASSOCIATED VIRUS SEROTYPE 9 (AAV9)
Titel:
PO-05-115 DETERMINING ELIGIBILITY FOR RIDGETM-1, A PHASE 1B INTERVENTIONAL STUDY TO EVALUATE SAFETY AND EFFICACY OF TN-401 GENE THERAPY IN ADULTS WITH PLAKOPHILIN-2 (PKP2)-ASSOCIATED ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY (ARVC): INTERIM RESULTS OF AN OBSERVATIONAL STUDY TO ASSESS SEROPREVALENCE TO ADENO-ASSOCIATED VIRUS SEROTYPE 9 (AAV9)
Auteur:
Paterson, Natasha Calkins, Hugh Barth, Andreas S. Vedantham, Vasanth Lakdawala, Neal K. Tang, W. H. Wilson Giudicessi, John R. Taylor, Matthew R. Pantazis, Antonis Chinitz, Larry A. Elliott, Perry Chevalier, Philippe Wang, Whedy Argast, Gretchen Tingley, Whit Gordon, Honerkamp Pollman, Matthew Priori, Silvia Giuliana G. Platonov, Pyotr G. Probst, Vincent Gerull, Brenda Coats, Caroline gandjbakhch, estelle
Verschenen in:
Heart rhythm
Paginering:
Jaargang 22 () nr. 4S pagina's S615
Jaar:
2025
Inhoud:
Uitgever:
Published by Elsevier B.V.
Bronbestand:
Elektronische Wetenschappelijke Tijdschriften
Details van artikel 541 van 1699 gevonden artikelen